Photosensitizers for Photodynamic Therapy of Brain Cancers-A Review

Overview

Journal Brain Sci

Publisher MDPI

Date 2023 Sep 28

PMID 37759900

Authors

Dorota Bartusik-Aebisher

Pawel Woznicki

Klaudia Dynarowicz

David Aebisher

Affiliations

Soon will be listed here.

Abstract

On average, there are about 300,000 new cases of brain cancer each year. Studies have shown that brain and central nervous system tumors are among the top ten causes of death. Due to the extent of this problem and the percentage of patients suffering from brain tumors, innovative therapeutic treatment methods are constantly being sought. One such innovative therapeutic method is photodynamic therapy (PDT). Photodynamic therapy is an alternative and unique technique widely used in dermatology and other fields of medicine for the treatment of oncological and nononcological lesions. Photodynamic therapy consists of the destruction of cancer cells and inducing inflammatory changes by using laser light of a specific wavelength in combination with the application of a photosensitizer. The most commonly used photosensitizers include 5-aminolevulinic acid for the enzymatic generation of protoporphyrin IX, Temoporfin-THPC, Photofrin, Hypericin and Talaporfin. This paper reviews the photosensitizers commonly used in photodynamic therapy for brain tumors. An overview of all three generations of photosensitizers is presented. Along with an indication of the limitations of the treatment of brain tumors, intraoperative photodynamic therapy and its possibilities are described as an alternative therapeutic method.

Citing Articles

Efficient Photosensitizer Delivery by Neutrophils for Targeted Photodynamic Therapy of Glioblastoma.

Wen R, Liu Y, Tian X, Xu Y, Chen X Pharmaceuticals (Basel). 2025; 18(2).

PMID: 40006088 PMC: 11859058. DOI: 10.3390/ph18020276.

The Activity of 1,8-Dihydroanthraquinone Derivatives in Nervous System Cancers.

Okon E, Kukula-Koch W, Jarzab A, Gawel-Beben K, Bator E, Michalak-Tomczyk M Molecules. 2025; 29(24.

PMID: 39770078 PMC: 11677425. DOI: 10.3390/molecules29245989.

Exploring the GSTP1 inhibition potential of photosensitizer compounds for enhanced cancer treatment in photodynamic therapy.

Ozcan M, Cicek C, Gok M Naunyn Schmiedebergs Arch Pharmacol. 2024; .

PMID: 39702601 DOI: 10.1007/s00210-024-03726-z.

Viral-Porphyrin Combo: Photodynamic and Oncolytic Viral Therapy for Potent Glioblastoma Treatment.

Nazarenko A, Shkirdova A, Orlova E, Biryukova Y, Vorovitch M, Kolyasnikova N Int J Mol Sci. 2024; 25(23).

PMID: 39684289 PMC: 11640982. DOI: 10.3390/ijms252312578.

Preclinical Photodynamic Therapy Targeting Blood Vessels with AGuIX Theranostic Nanoparticles.

Kowolik E, Szczygiel D, Szczygiel M, Drzal A, Vemuri K, Olsson A Cancers (Basel). 2024; 16(23).

PMID: 39682113 PMC: 11640380. DOI: 10.3390/cancers16233924.

References

Tsukagoshi S . [Porfimer sodium (Photofrin-II)]. Gan To Kagaku Ryoho. 1995; 22(9):1271-8. View

Ibarra L, Porcal G, Macor L, Ponzio R, Spada R, Lorente C . Metallated porphyrin-doped conjugated polymer nanoparticles for efficient photodynamic therapy of brain and colorectal tumor cells. Nanomedicine (Lond). 2018; 13(6):605-624. DOI: 10.2217/nnm-2017-0292. View

Paszko E, Ehrhardt C, Senge M, Kelleher D, Reynolds J . Nanodrug applications in photodynamic therapy. Photodiagnosis Photodyn Ther. 2011; 8(1):14-29. DOI: 10.1016/j.pdpdt.2010.12.001. View

Waite C, Roth C . Nanoscale drug delivery systems for enhanced drug penetration into solid tumors: current progress and opportunities. Crit Rev Biomed Eng. 2012; 40(1):21-41. PMC: 3639314. DOI: 10.1615/critrevbiomedeng.v40.i1.20. View

Kamoshima Y, Terasaka S, Kuroda S, Iwasaki Y . Morphological and histological changes of glioma cells immediately after 5-aminolevulinic acid mediated photodynamic therapy. Neurol Res. 2011; 33(7):739-46. DOI: 10.1179/1743132810Y.0000000001. View

Mahmoudi K, Garvey K, Bouras A, Cramer G, Stepp H, Jesu Raj J . 5-aminolevulinic acid photodynamic therapy for the treatment of high-grade gliomas. J Neurooncol. 2019; 141(3):595-607. PMC: 6538286. DOI: 10.1007/s11060-019-03103-4. View

Johansson A, Palte G, Schnell O, Tonn J, Herms J, Stepp H . 5-Aminolevulinic acid-induced protoporphyrin IX levels in tissue of human malignant brain tumors. Photochem Photobiol. 2010; 86(6):1373-8. DOI: 10.1111/j.1751-1097.2010.00799.x. View

Girotti A, Fahey J, Korytowski W . Multiple Means by Which Nitric Oxide can Antagonize Photodynamic Therapy. Curr Med Chem. 2016; 23(24):2754-2769. DOI: 10.2174/0929867323666160812145641. View

Xu D, Chen X, Chen K, Peng Y, Li Y, Ke Y . Tetra-sulfonate phthalocyanine zinc-bovine serum albumin conjugate-mediated photodynamic therapy of human glioma. J Biomater Appl. 2014; 29(3):378-85. DOI: 10.1177/0885328214529466. View

10.

Bhanja D, Wilding H, Baroz A, Trifoi M, Shenoy G, Slagle-Webb B . Photodynamic Therapy for Glioblastoma: Illuminating the Path toward Clinical Applicability. Cancers (Basel). 2023; 15(13). PMC: 10341187. DOI: 10.3390/cancers15133427. View

11.

Muller P, Abdel Gaber S, Zimmermann W, Wittig R, Stepp H . ABCG2 influence on the efficiency of photodynamic therapy in glioblastoma cells. J Photochem Photobiol B. 2020; 210:111963. DOI: 10.1016/j.jphotobiol.2020.111963. View

12.

Aldosari L, Bin Hassan S, Alshadidi A, Rangaiah G, Divakar D . Short-term influence of antimicrobial photodynamic therapy as an adjuvant to mechanical debridement in reducing soft-tissue inflammation and subgingival yeasts colonization in patients with peri-implant mucositis. Photodiagnosis Photodyn Ther. 2023; 42:103320. DOI: 10.1016/j.pdpdt.2023.103320. View

13.

Kim H, Seo M, Park T, Lee D . A novel therapeutic strategy of multimodal nanoconjugates for state-of-the-art brain tumor phototherapy. J Nanobiotechnology. 2022; 20(1):14. PMC: 8725459. DOI: 10.1186/s12951-021-01220-9. View

14.

De Groof T, Mashayekhi V, Fan T, Bergkamp N, Torano J, van Senten J . Nanobody-Targeted Photodynamic Therapy Selectively Kills Viral GPCR-Expressing Glioblastoma Cells. Mol Pharm. 2019; 16(7):3145-3156. PMC: 6728091. DOI: 10.1021/acs.molpharmaceut.9b00360. View

15.

Vitorio G, de Almeida R, Pinto J, Fontana L, Ferreira-Strixino J . Analysis of the effects of Photodynamic therapy with Photodithazine on the treatment of 9l/lacZ cells, in vitro study. Photodiagnosis Photodyn Ther. 2021; 34:102233. DOI: 10.1016/j.pdpdt.2021.102233. View

16.

Ray P, Huang B, Tsuji Y . Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling. Cell Signal. 2012; 24(5):981-90. PMC: 3454471. DOI: 10.1016/j.cellsig.2012.01.008. View

17.

Olivier D, Bourre L, El-Sabbagh E, Loussouarn D, Simonneaux G, Valette F . Photodynamic effects of SIM01, a new sensitizer, on experimental brain tumors in rats. Surg Neurol. 2007; 68(3):255-63. DOI: 10.1016/j.surneu.2006.10.072. View

18.

Ibarra L, Vilchez M, Caverzan M, Milla Sanabria L . Understanding the glioblastoma tumor biology to optimize photodynamic therapy: From molecular to cellular events. J Neurosci Res. 2020; 99(4):1024-1047. DOI: 10.1002/jnr.24776. View

19.

Li X, Feng H, Li F . [Progression of basic research, clinical application of photodynamic therapy and fluorescence-guided surgery in glioma treatment]. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2018; 43(4):360-367. DOI: 10.11817/j.issn.1672-7347.2018.04.005. View

20.

Kessel D . Hypericin Accumulation as a Determinant of PDT Efficacy. Photochem Photobiol. 2020; 96(5):1144-1147. DOI: 10.1111/php.13302. View